Department of Nephrology, Cliniques Universitaires St Luc, Bruxelles, Belgium.
Adv Chronic Kidney Dis. 2010 Mar;17(2):173-80. doi: 10.1053/j.ackd.2010.01.003.
Although asymptomatic in most patients, extrarenal manifestations of ADPKD may become more clinically relevant with the increasing life expectancy of affected patients. They mainly encompass cysts in other organs than the kidney (liver: 94%, seminal vesicle: 40%, pancreas: 9%, arachnoid membrane: 8%, and spinal meningeal, 2%) and connective tissue abnormalities (mitral valve prolapse: 25%, intracranial aneurysms: 8%, and abdominal hernia: 10%). Their recognition may spare the patient from other, useless investigations (eg, when an arachnoid cyst is incidentally found) or lead to the implementation of prophylactic or therapeutic measures (eg, screening, sometimes followed by the treatment of an asymptomatic intracranial aneurysm in at-risk patients, or, in the presence of a severe polycystic liver disease, avoidance from estrogens and treatment aimed to slow cyst growth).
虽然在大多数患者中无症状,但随着 ADPKD 患者预期寿命的延长,其肾脏以外的表现可能会变得更加具有临床意义。它们主要包括肾脏以外的其他器官中的囊肿(肝脏:94%,精囊:40%,胰腺:9%,蛛网膜:8%,脊髓脑膜:2%)和结缔组织异常(二尖瓣脱垂:25%,颅内动脉瘤:8%,和腹疝:10%)。识别这些表现可以使患者避免其他无用的检查(例如,当意外发现蛛网膜囊肿时),或者采取预防性或治疗性措施(例如,对有风险的患者进行无症状颅内动脉瘤的筛查,有时随后进行治疗,或者在存在严重多囊肝病的情况下,避免使用雌激素并采取治疗措施以减缓囊肿生长)。